Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
This study has been terminated.
( low enrollment )
Study NCT00655226   Information provided by Mount Sinai School of Medicine

First Received on April 3, 2008.   Last Updated on August 5, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis C
Depressive Disorder, Major
Depressive Disorder
Depression
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Hepatitis
Hepatitis A
Substance-Related Disorders
More general conditions related to this trial
Behavioral Symptoms
Digestive System Diseases
Enterovirus Infections
Flaviviridae Infections
Hepatitis, Viral, Human
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Liver Diseases
Mental Disorders
Mood Disorders
Picornaviridae Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Sponsors listed in this trial
Mount Sinai School of Medicine
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services